Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10966141 | Vaccine | 2013 | 6 Pages |
Abstract
There is currently no indigenous vaccine production in sub-Saharan Africa and only one facility, based in South Africa, capable of filling imported bulk. Innovative vaccine strategies will need to be explored, such as maternal immunisation, and also the possibility of other influenza vaccine options, such as live attenuated influenza vaccine for young children. Sustained indigenous vaccine production is essential for the continent to have vaccine security in the event of a pandemic even though establishing local production faces considerable challenges especially ensuring adequate markets on the continent. There is an urgent need to develop effective communication messages for decision makers as well as healthcare workers addressing the importance of influenza even in the face of the major competing health burdens of the continent.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Barry D. Schoub, Bradford D. Gessner, William Ampofo, Adam L. Cohen, Christoph A. Steffen,